[PDF][PDF] Diagnosis and progress in biological treatment of osteosarcoma
X Xie, T Lin, Z Liu, H Tang, Q Zhong, L Cheng - HJBM, 2019 - pdf.hanspub.org
Osteosarcoma is a primary malignant tumor that seriously threatens the health and life of
patients. With the development of medical science and technology, treatment methods are …
patients. With the development of medical science and technology, treatment methods are …
[PDF][PDF] 人细胞基因组AAVS1 位点基因定点整合率的荧光定量PCR 检测方法
张轶岭， 王飞飞， 张春， 李文生 - 生命科学研究 - smkx.hunnu.edu.cn
… 文中的 CAR 指的是嵌合抗原受体(chimeric antigen receptor).CELiD 和pCMV-Rep 共转染细胞
… CH, Levine B L. Engineered T cells: the promise and challenges of cancer immunotherapy[J]…
… CH, Levine B L. Engineered T cells: the promise and challenges of cancer immunotherapy[J]…
嵌合抗原受体(CAR) 技术在血液肿瘤免疫治疗中的研究进展与应用前景
赵嫄 - 2014 - ir.lzu.edu.cn
… Chimeric antigen receptor(CAR) technique in hematological … 但是生理性的T细胞表面受
体(T cell receptor, TCR)识别肿瘤… for the treatment of hematologic malignancies.Adoptive …
体(T cell receptor, TCR)识别肿瘤… for the treatment of hematologic malignancies.Adoptive …
嵌合抗原受体T 细胞疗法及其在血液肿瘤免疫治疗中的应用.
夏莉， 王月英 - Journal of Shanghai Jiaotong University …, 2017 - search.ebscohost.com
… English Chimeric antigen receptor T-cell (CAR-T) … effector T cells that specially recognize
tumor-associated antigen was … of CAR-T in hematological malignancies immunotherapy were …
tumor-associated antigen was … of CAR-T in hematological malignancies immunotherapy were …
CAR-T 细胞治疗实体瘤的归巢障碍及解决方法
杨松林， 李琳， 段德仁， 侯宗柳， 谭晶 - 中国肿瘤临床, 2019 - cjco.cn
… Abstract: Chimeric antigen receptor T (CAR-T) cell therapy is … in the treatment of hematological
neoplasms. However, little … of CAR-T cells in the treatment of solid tumors but also the …
neoplasms. However, little … of CAR-T cells in the treatment of solid tumors but also the …
合成生物学与工程化T 细胞治疗
谢君鸿， 何晶晶， 周鹏辉 - 合成生物学, 2023 - synbioj.cip.com.cn
… effect against malignant blood tumors, TCR-T cell therapies … T细胞,主要包括T细胞受体工
程T细胞(T-cell receptor-engineered T cell, TCR-T) 疗法和嵌合抗原受体T 细胞(chimeric antigen …
程T细胞(T-cell receptor-engineered T cell, TCR-T) 疗法和嵌合抗原受体T 细胞(chimeric antigen …
BCMA CAR-T 细胞治疗的耐药机制及优化策略研究
李运佳， 刘卓刚， 胡荣 - 中国肿瘤临床, 2023 - cjco.cn
… Abstract: Chimeric antigen receptor T cell (CAR-T) therapy has produced remarkable results
in the treatment of hematological tumors. The BCMA antigen is widely expressed on the …
in the treatment of hematological tumors. The BCMA antigen is widely expressed on the …
双靶向CAR T 细胞治疗难治性多发性骨髓瘤后出现巨核细胞再障: 病例报告
刘尚勤， 桂成思 - Oncology and Translational Medicine, 2021 - otm.tjh.com.cn
… Chimeric antigen receptor (CAR) T-cell therapy is an effective new treatment strategy for
hematologic malignancies… the initial results of CAR T cell therapy have been encouraging. CAR …
hematologic malignancies… the initial results of CAR T cell therapy have been encouraging. CAR …
CAR-T 抗肿瘤研究的现状及展望
郑敏， 张岚 - 山东大学学报(医学版), 2016 - yxbwk.njournal.sdu.edu.cn
… and effective cancer therapeutics. A novel breakthrough has been made in CAR-T treatment
of hematologic tumors and therapeutic potential in clinical studies of solid tumors has been …
of hematologic tumors and therapeutic potential in clinical studies of solid tumors has been …
血液肿瘤CAR-T 细胞治疗的现状与挑战
康云， 梅恒， 胡豫 - 中国肿瘤临床, 2023 - cjco.cn
… 的T 细胞(chimeric antigen receptor-modified T cells,CAR-T)… of CAR-T cell therapies in
hematological malignancies and … 工程 T 细胞(T cell receptor engineered T cells,TCR-T)以 及…
hematological malignancies and … 工程 T 细胞(T cell receptor engineered T cells,TCR-T)以 及…